Skip to content
PHOENIX SEP
Single Entry Point for Nano-pharmaceutical Innovative Products
PHOENIX SEP
  • Home
  • About
  • Services
  • FAQ
  • News & Events
  • Contact
  • Search App
  • Home
  • About
  • Services
  • FAQ
  • News & Events
  • Contact
  • Search App

Matthias Jourdain

You are here:
  1. Home
  2. Article author Matthias Jourdain
Jul12025

Video PHOENIX SEP: Your Single Entry Point for Nanopharmaceutical Development

News1. July 2025

PHOENIX provides a Single Entry Point (SEP) for a network of facilities, technologies, services and expertise for all the R&D/I…

Read more
Apr102025

PHOENIX SEP Rises at Barcelona Event

Events, News10. April 2025

PHOENIX SEP, as a single entry point to a variety of services along the nanopharmaceutical value chain, will be introduced…

Read more
Feb72025

PHOENIX SEP enters European R&I with the DESIDERATA project

News7. February 2025

PHOENIX SEP enters the European Framework Programme for Research and Innovation and supports The European Commission’s safe and sustainable by…

Read more
Jan162025

NaDeNo Gains Access to Nanopharmaceutical Development Services in 2nd Open Call

News16. January 2025

NaDeNo Nanoscience AS was selected to receive pro bono services to accelerate the development of their nanomedicine.

Read more
Nov212024

PHOENIX at PODD in Boston

Events21. November 2024

PHOENIX was present at the Partnership Opportunities in Drug Delivery (PODD) in Boston from 28-29 October 2024.

Read more
Jul262024

PHOENIX booth at ECCPM Forum

Events26. July 2024

PHOENIX will be at the ECCPM Forum, which welcomes attendees from diverse pharmaceutical organizations worldwide and features key note lectures…

Read more
→12→


Downloads | Legal Notice | Privacy Policy

Go to Top